期刊文献+

奥曲肽联合艾司奥美拉唑治疗非静脉曲张性上消化道出血的疗效观察 被引量:12

Efficacy of octreotide plus esomeprazole in non-variceal upper gastrointestinal bleeding
下载PDF
导出
摘要 目的:比较奥曲肽联合艾司奥美拉唑与单独使用艾司奥美拉唑治疗非静脉曲张性上消化道出血的疗效。方法:选取2017年4月至2020年2月在广州市荔湾中心医院住院治疗的78例非静脉曲张性上消化道出血患者作为研究对象,按照随机数字表法分为联合组(奥曲肽联合艾司奥美拉唑,n=39)和对照组(单用艾司奥美拉唑,n=39)。比较两组总有效率、平均出血时间、再出血率、不良反应等指标。结果:联合组治疗后总有效率为94.9%,高于对照组的79.5%(P<0.05);联合组平均出血时间短于对照组(P<0.05);联合组再出血率低于对照组(P<0.05);两组患者治疗后均无不良反应。结论:奥曲肽联合艾司奥美拉唑治疗非静脉曲张性上消化道出血疗效显著,有利于降低再出血率、缩短出血时间。 Objective:To compare the efficacy of octreotide plus esomeprazole vs esomeprazole alone in the treatment of non-variceal upper gastrointestinal bleeding.Methods:Enrolled were 78 patients with non-variceal upper gastrointestinal bleeding in Liwan Central Hospital of Guangzhou between April 2017 and February 2020.The subjects were randomized into a combination group(octreotide plus esomeprazole,n=39)and a control group(esomeprazole alone,n=39)according to random number table.The total treatment respone,mean duration of bleeding,relapse of bleeding,and adverse reactions were compared between the two groups.Results:The total treatment response in the combination group was 94.9%,which was higher than that(79.5%)in the control group(P<0.05).The mean duration of bleeding in the combination group was shorter than that in the control group(P<0.05).Fewer patients in the combination group experienced relapse of bleeding compared with the control group(P<0.05).There were no adverse reactions in the two groups after treatment.Conclusion:Octreotide plus esomeprazole is significantly effective as a treatment of non-variceal upper gastrointestinal bleeding,with advantages in terms of less relapse of bleeding and shorter duration of bleeding.
作者 叶依霞 司徒树标 倪东升 Ye Yixia;Situ Shubiao;Ni Dongsheng(Department of Gastroenterology,Liwan Central Hospital,Guangzhou 510000,China)
出处 《广州医科大学学报》 2021年第4期60-62,66,共4页 Academic Journal of Guangzhou Medical University
关键词 上消化道出血 非静脉曲张性 艾司奥美拉唑 奥曲肽 Upper gastrointestinal bleeding,Non-variceal Esomeprazole Octreotide
  • 相关文献

参考文献4

二级参考文献62

  • 1Longstreth GF. Epidemiology and outcome of patients hos- pitalized with acute lower gastrointestinal hemorrhage: a population-based study. Am J Gastroentero11997; 92:419-424.
  • 2Wara P. Incidence, diagnosis, and natural course of upper gastrointestinal hemorrhage. Prognostic value of clinical factors and endoscopy. Scand J Gastroenterol Suppl 1987; 137: 26-27.
  • 3Brzozowski T, Konturek PC, Sliwowski Z, Kwiecien S, Drozdowicz D, Pawlik M, Mach K, Konturek SJ, Pawlik WW. Interaction of nonsteroidal anti-inflammatory drugs (NSAID) with Helicobacter pylori in the stomach of humansand experimental animals. J Physiol Pharmaco12006; 57 Suppl 3:67-79.
  • 4Barkun A, Sabbah S, Enns R, Armstrong D, Gregor J, Fedor- ak RN, Rahme E, Toubouti Y, Martel M, Chiba N, Fallone CA. The Canadian Rel~istry on Nonvariceal Upper Gastro-intestinal Bleeding and Endoscopy (RUGBE): Endoscopic hemostasis and proton pump inhibition are associated with improved outcomes in a real-life setting. Am J Gastroenterol 2004; 99:1238-1246.
  • 5Lim CH, Vani D, Shah SG, Everett SM, Rembacken BJ. The outcome of suspected upper gastrointestinal bleeding with 24-hour access to upper gastrointestinal endoscopy: a pro- spective cohort study. Endoscopy 2006; 38:581-585.
  • 6Vreeburg EM, Levi M, Rauws EA, Deventer SJ, Snel P, Bar- telsman JW, Ten Cate JW, Tytgat GN. Enhanced mucosal fibrinolytic activity in gastroduodenal ulcer haemorrhage and the beneficial effect of acid suppression. Aliment Phar- macol Ther 2001; 15:639-646.
  • 7Patchett SE, O'Donoghue DP. Pharmacological manipula- tion of gastric juice: thrombelastographic assessment and implications for treatment of gastrointestinal haemorrhage. Gut 1995; 36:358-362.
  • 8Keyvani L, Murthy S, Leeson S, Targownik LE. Pre-endo- scopic proton pump inhibitor therapy reduces recurrent ad- verse gastrointestinal outcomes in patients with acute non- variceal upper gastrointestinal bleeding. Aliment Pharmacol Ther 2006; 24:1247-1255.
  • 9Bardou M, Toubouti Y, Benhaberou-Brun D, Rahme E, Barkun AN. Meta-analysis: proton-pump inhibition in high- risk patients with acute peptic ulcer bleeding. Aliment Phar- macol Ther 2005; 21:677-686.
  • 10Barkun AN. The role of intravenous proton pump inhibi- tors in the modern management of nonvariceal upper gas- trointestinal bleeding. Drugs Today (Barc) 2003; 39 Suppl A: 3-10.

共引文献239

同被引文献152

引证文献12

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部